# Vaxxas

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vaxxas-pty

- Industry: Biotechnology
- Headquarters: Australia
- Website: www.vaxxas.com
- Total disclosed funding: $124M
- Latest round: Series D (Aug 25, 2025)
- Investors on record: 10

## About

Founded in 2011 and based in Sydney, Australia, Vaxxas Pty Ltd develops and commercializes a needle-free vaccine delivery system. The company focuses on enhancing the performance of existing and future vaccines through the development and commercialization of the company's novel vaccine delivery technology - the Nanopatch™. Vaxxas Pty Ltd raised an undisclosed amount of venture funding from new investor Prisma Investments. Vaxxas Pty Ltd offers research and development of vaccines with the goal of improving health conditions. In August 2025, Vaxxas Pty Ltd raised USD 49 million in series D funding from new investor LGT Crestone Wealth Management, with participation from returning investors Brandon Capital Partners and OneVentures. The round was part of a larger USD 89 million series D and venture debt funding. The company will use the funding to expand production of its needle-free vaccine patches and support clinical trials to test their safety and effectiveness.

## Funding rounds

- Series D, Aug 25, 2025, $49M — Brandon Capital Partners, OneVentures, LGT Wealth Management Australia, Sprim Ventures
- Series C, Dec 5, 2022, $23M — OneVentures, UniQuest Limited
- Series C, May 1, 2020, $14M — OneVentures, Merck & Co., Inc., Himstedt & Co Pty Ltd
- Series B, Aug 20, 2019, $5.7M — HealthCare Ventures, QIC, OneVentures, Jubilant Pharma Limited, Himstedt & Co Pty Ltd
- Series B, Apr 30, 2018, $6.9M — OneVentures, Himstedt & Co Pty Ltd
- Series B, May 31, 2017, $2.6M — OneVentures
- Series B, Apr 20, 2016, $3.9M — OneVentures, Himstedt & Co Pty Ltd
- Series B, Feb 27, 2015, $6.1M — OneVentures, Himstedt & Co Pty Ltd
- Series A, Jun 12, 2014, $2.1M — HealthCare Ventures, Brandon Capital Partners, OneVentures, UniQuest Limited
- Series A, Jun 14, 2013, $1.9M — HealthCare Ventures, Brandon Capital Partners, OneVentures, UniQuest Limited
- Series A, Apr 24, 2012, $5.9M — HealthCare Ventures, Brandon Capital Partners, OneVentures, UniQuest Limited
- Series A, Sep 13, 2011, $2.4M — HealthCare Ventures, Brandon Capital Partners, OneVentures, UniQuest Limited

## Investors

- HealthCare Ventures — Series A, Series B
- Brandon Capital Partners (https://capitalatlas.ai/funds/brandon-capital-partners) — Series A, Series D
- OneVentures (https://capitalatlas.ai/funds/oneventures) — Series A, Series B, Series C, Series D
- UniQuest Limited — Series A, Series C
- Himstedt & Co Pty Ltd — Series B, Series C
- QIC (https://capitalatlas.ai/funds/qic) — Series B
- Jubilant Pharma Limited — Series B
- Merck & Co., Inc. — Series C
- LGT Wealth Management Australia — Series D
- Sprim Ventures (https://capitalatlas.ai/funds/sprim-ventures) — Series D